Inflammatory parameters and prediction of prognosis in infective endocarditis

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Cornelissen, Christian G ^a   Frechen, Dirk A ^a   Schreiner, Karin ^a   Marx, Nikolaus ^a   Krüger, Stefan ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; PROCALCITONIN;

ABSCESS; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIUM DETECTION; BLOOD CULTURE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART FAILURE; HORMONE ACTION; HORMONE DETERMINATION; HOSPITALIZATION; HUMAN; INFECTION COMPLICATION; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MICROBIOLOGICAL EXAMINATION; OSTEOMYELITIS; OUTCOME ASSESSMENT; PATHOGENESIS; PREDICTIVE VALUE; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEPTIC SHOCK; STANDARD; STAPHYLOCOCCUS AUREUS;

ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CALCITONIN; ENDOCARDITIS; FEMALE; HUMANS; INFLAMMATION; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PROGNOSIS; PROTEIN PRECURSORS; RETROSPECTIVE STUDIES; ROC CURVE; YOUNG ADULT;

EID: 84878894544     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-272     Document Type: Article

References (27)

1. Hecht SR, Berger M. Right-sided endocarditis in intravenous drug users: prognostic features in 102 episodes. Ann Intern Med 1992, 117:560-566. 10.7326/0003-4819-117-7-560, 1524330.
2. Romano G, Carozza A, Della Corte A, De Santo LS, Amarelli C, Torella M, De Feo M, Cerasuolo F, Cotrufo M. Native versus primary prosthetic valve endocarditis: comparison of clinical features and long-term outcome in 353 patients. J Heart Valve Dis 2004, 13:200-208.
3. Hasbun R, Vikram HR, Barakat LA, Buenconsejo J, Quagliarello VJ. Complicated left-sided native valve endocarditis in adults: risk classification for mortality. JAMA 2003, 289:1933-1940. 10.1001/jama.289.15.1933, 12697795.
4. Di Salvo G, Thuny F, Rosenberg V, Pergola V, Belliard O, Derumeaux G, Cohen A, Iarussi D, Giorgi R, Casalta JP, Caso P, Habib G. Endocarditis in the elderly: clinical, echocardiographic, and prognostic features. Eur Heart J 2003, 24:1576-1583. 10.1016/S0195-668X(03)00309-9, 12927193.
5. Cabell CH, Pond KK, Peterson GE, Durack DT, Corey GR, Anderson DJ, Ryan T, Lukes AS, Sexton DJ. The risk of stroke and death in patients with aortic and mitral valve endocarditis. Am Heart J 2001, 142:75-80. 10.1067/mhj.2001.115790, 11431660.
6. Durante Mangoni E, Adinolfi LE, Tripodi MF, Andreana A, Gambardella M, Ragone E, Precone DF, Utili R, Ruggiero G. Risk factors for " major" embolic events in hospitalized patients with infective endocarditis. Am Heart J 2003, 146:311-316. 10.1016/S0002-8703(02)94802-7, 12891201.
7. van der Meer JT, Thompson J, Valkenburg HA, Michel MF. Epidemiology of bacterial endocarditis in the Netherlands, I: patient characteristics. Arch Intern Med 1992, 152:1863-1868. 10.1001/archinte.1992.00400210087014, 1520052.
8. Verhagen DWM, Hermanides J, Korevaar JC, Bossuyt PM, van den Brink RB, Speelman P, van der Meer JT. Prognostic value of serial C-reactive protein measurements in left-sided native valve endocarditis. Arch Intern Med 2008, 168:302-307. 10.1001/archinternmed.2007.73, 18268172.
9. Olaison L, Hogevik H, Alestig K. Fever, CRP and other acute-phase reactants during treatment of infective endocarditis. Arch Intern Med 1997, 157:885-892. 10.1001/archinte.1997.00440290069007, 9129548.
10. Heiro M, Helenius H, Sundell J, Koskinen P, Engblom E, Nikoskelainen J, Kotilainen P. Utility of serum CRP in assessing the outcome of infective endocarditis. Eur Heart J 2005, 26:1873-1881. 10.1093/eurheartj/ehi277, 15855194.
11. Ostrowski S, Marcinkiewicz A, Nowak D, Zwolilski R, Jaszewski R. Comparison of the clinical application of reactive oxygen species and inflammatory markers in patients with endocarditis. Arch Med Sci 2012, 8:244-249. 3361036, 22661996.
12. Jereb M, Kotar T, Jurca T, Lejko ZT. Usefulness of procalcitonin for diagnosis of infective endocarditis. Intern Emerg Med 2009, 4:221-6.
13. Mueller C, Huber P, Laifer G, Mueller B, Perruchoud AP. Procalcitonin and the early diagnosis of infective endocarditis. Circulation 2004, 109:1707-10. 10.1161/01.CIR.0000126281.52345.52, 15066945.
14. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 1994, 96(3):200-9. 10.1016/0002-9343(94)90143-0, 8154507.
15. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke Criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000, 30:633-638. 10.1086/313753, 10770721.
16. Knudsen JB, Fuursted K, Petersen E, Wierup P, Mølgaard H, Poulsen SH, Egeblad H. Procalcitonin in 759 patients clinically suspected of infective endocarditis. Am J Med 2010, 123:1121-27. 10.1016/j.amjmed.2010.07.018, 20870199.
17. Chu V, Cabell C, Benjamin D, Kuniholm E, Fowler V, Engemann J, Sexton D, Corey R, Wang A. Early Predictors of In-Hospital Death in Infective Endocarditis. Circulation 2004, 109:1745-1749. 10.1161/01.CIR.0000124719.61827.7F, 15037538.
18. Kocazeybek B, Kücükoglu S, Öner Y. Procalcitonin and C-Reactive Protein in Infective Endocarditis: Correlation with Etiology and Prognosis. Chemotherapy 2003, 49:76-84. 10.1159/000069777, 12714816.
19. López J, Revilla A, Vilacosta I, Sevilla T, Villacorta E, Sarriá C, Pozo E, Rollán MJ, Gómez I, Mota P, San Román JA. Age-dependent profile of left-sided infective endocarditis: a 3-center experience. Circulation 2010, 121:892-7. 10.1161/CIRCULATIONAHA.109.877365, 20142448.
20. Christ-Crain M, Müller B. Biomarkers in respiratory tract infections:diagnostic guides to antibiotic prescription, prognostic markers and mediators. Eur Respir J 2007, 30:556-573. 10.1183/09031936.00166106, 17766633.
21. Shiue AB, Stancoven AB, Purcell JB, Pinkston K, Wang A, Khera A, de Lemos JA, Peterson GE. Relation of level of B-type natriuretic peptide with outcomes in patients with infective endocarditis. Am J Cardiol 2010, 106:1011-1015. 10.1016/j.amjcard.2010.05.034, 20854966.
22. Kahveci G, Bayrak F, Mutlu B, Bitigen A, Karaahmet T, Sonmez K, Izgi A, Degertekin M, Basaran Y. Prognostic value of N-terminal pro-B-type natriuretic peptide in patients with active infective endocarditis. Am J Cardiol 2007, 99:1429-1433. 10.1016/j.amjcard.2006.12.071, 17493474.
23. Assicot M, Genderel D, Carsin H, Raymond J, Guilbaud J, Bohoun C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993, 341:151-518.
24. Schuetz P, Christ-Crain M, Thomann R, et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA 2009, 302:1059-1066. 10.1001/jama.2009.1297, 19738090.
25. Krüger S, Ewig S, Marre R, Papassotiriou J, Richter K, von Baum H, Suttorp N, Welte T. Procalcitonin predicts patients at low risk of death from community- acquired pneumonia. Eur Resp J 2008, 31:349-355.
26. Krüger S, Ewig S, Papassotiriou J, Kunde J, Marre R, von Baum H, Suttorp N, Welte T, and The CAPNETZ Study group Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP - Results from the German competence network CAPNETZ. Respir Res 2009, 10:65. 10.1186/1465-9921-10-65, 2714042, 19594893, and The CAPNETZ Study group.
27. Krüger S, Ewig S, Giersdorf S, Hartmann O, Suttorp N, Welte T, and The CAPNETZ Study group Cardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumonia. Results from the German competence network CAPNETZ. Am J Respir Crit Care Med 2010, 182:1426-34. 10.1164/rccm.201003-0415OC, 20639437, and The CAPNETZ Study group.